Women’s Health/STD Panel

PCL’s Women’s Health/STD Panel is focused on serving:

  • OBGYNs
  • Infectious Disease Practitioners
  • Geriatric, Primary Care & Family Physicians
  • Skilled Nursing Facilities

Women’s Health/STD Panel Benefits

  • PCR molecular technology solutions can detect microbes that are slow growing, difficult to grow or fail to grow under traditional methods providing clear, precise categorization of the microorganisms involved.
  • The implications of quickly diagnosing women’s health infections extend far beyond that of each patient, it can affect their partners and even their children.
  • It is critical for diagnostic tests for STDs to not only aid in the diagnosis of typical cases but also atypical cases, asymptomatic infections and also multiple infections.

Women’s Health/STD Statistics

  • In 2019, a total of 1,808,703 cases of Chlamydia trachomatis infection were reported to the CDC making it the most common notifiable condition in the United States for that year.
  • In the United States, there were an estimated 2.6 million trichomoniasis infections in 2018. Trichomoniasis can increase the risk of getting or spreading HIV, and pregnant women with the infection are more likely to have preterm delivery and with a low birth weight.

The Women’s Health/STD Panel detects the following:

  • BACTERIAL
    • Atopobium vaginae
    • Bacteroides fragilis
    • BVAB2
    • Chlamydia trachomatis
    • Enterococcus faecalis
    • Escherichia coli
    • Gardnerella vaginalis
    • Haemophilus ducreyi
    • Lactobacillus crispatus
    • Lactobacillus gasseri
    • Lactobacillus iners
    • Lactobacillus jensenii
    • Megasphaera 1
    • Megasphaera 2
    • Mobiluncus curtisii
    • Mobiluncus mulieris
    • Mycoplasma genitalium
    • Mycoplasma hominis
    • Neisseria gonorrhoeae
    • Prevotella bivia
    • Staphylococcus aureus
    • Streptococcus agalactiae (group B)
    • Treponema pallidum (Syphilis)
    • Ureaplasma urealyticum
  • FUNGAL
    • Candida albicans
    • Candida dubliniensis 
    • Candida glabrata
    • Candida krusei
    • Candida lusitaniae
    • Candida parapsilosis
    • Candida tropicalis
    • Trichomonas vaginalis
  • VIRAL
    • HSV1
    • HSV2

Results will become available online within 24 to 48 hours of specimen receipt followed by hard copy in the mail and fax if requested.